Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in Indonesia: A Single-Blinded Randomized Controlled Trial

<b>Background</b>: Numerous studies have proved the efficacy of vaccination in reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmission and the coronavirus disease (COVID-19) burden. However, even though the COVID-19 vaccination coverage is high for primary doses, a booster...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nina Dwi Putri, Aqila Sakina Zhafira, Pratama Wicaksana, Hindra Irawan Satari, Eddy Fadlyana, Vivi Safitri, Nurlailah Nurlailah, Edwinaditya Sekar Putri, Nidya Putri, Devi Surya Iriyani, Yunita Sri Ulina, Frizka Aprilia, Evi Pratama, Indri Nethalia, Rita Yustisiana, Erlin Qur’atul Aini, Rini Fajarani, Adityo Susilo, Mulya Rahma Karyanti, Ari Prayitno, Hadyana Sukandar, Emma Watts, Nadia Mazarakis, Pretty Multihartina, Vivi Setiawaty, Krisna Nur Andriana Pangesti, Agnes Rengga Indrati, Julitasari Sundoro, Dwi Oktavia Handayani, Cissy B. Kartasasmita, Sri Rezeki Hadinegoro, Kim Mulholland
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-11-01
Colecção:	Vaccines
Assuntos:	COVID-19 vaccine booster half-dose
Acesso em linha:	https://www.mdpi.com/2076-393X/13/11/1149
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!